A recent after-hours trading session saw significant gains for several biotech and cannabis stocks, notably Tilray Brands, Inc. This surge followed recent corporate developments and trader momentum.
Tilray Brands’ After-Hours Surge
Tilray experienced a remarkable increase of 11.36%, reaching $13.53. This jump comes after a volatile week marked by a one-for-ten reverse stock split, effective from December 1. On the preceding trading day, shares closed at $12.15, reflecting a staggering 44.13% rise within that day.
Investors are currently focused on Tilray’s strategic restructuring and its recently released 2025 Holiday Drink Gift Guide. The guide showcases the expansion of Tilray’s beverage offerings throughout North America, further fueling investor interest.
Other Notable Stocks
- Valneva SE (VALN): Up by 7.22%, reaching $9.31. The company rebounded from a prior decline of 3.45% after announcing positive final data from its Phase 2 chikungunya vaccine trial in children.
- Chemomab Therapeutics Ltd. (CMMB): Increased by 7.66%, trading at $2.39. The stock reversed a nearly 6% drop, reacting positively to results from its Phase 2 SPRING trial published in a leading medical journal.
- Genenta Science S.p.A. (GNTA): Rose by 12.06% to $1.58. The rise follows the disclosure of updated data from their TEM-GBM study concerning glioblastoma.
- Kazia Therapeutics Limited (KZIA): Gained 10.93%, reaching $11.57 after recovering from a prior 20% decline. Recent presentations have highlighted promising data for their PI3K/mTOR inhibitor.
- Traws Pharma, Inc. (TRAW): Increased by 8.81% to $2.54, despite no significant developments in trading. The stock remains active due to low-float momentum.
The healthcare and biotech sectors are showing considerable volatility, as evidenced by these after-hours movements. The combination of recent company announcements and trader speculation continues to drive investor interest in these stocks.
